Essex Investment Management CO LLC Arcutis Biotherapeutics, Inc. Transaction History
Essex Investment Management CO LLC
- $516 Million
- Q4 2024
A detailed history of Essex Investment Management CO LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 142,823 shares of ARQT stock, worth $2.25 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
142,823
Previous 163,964
12.89%
Holding current value
$2.25 Million
Previous $1.52 Million
30.51%
% of portfolio
0.39%
Previous 0.28%
Shares
3 transactions
Others Institutions Holding ARQT
# of Institutions
218Shares Held
129MCall Options Held
2.02MPut Options Held
202K-
Jennison Associates LLC12.3MShares$194 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.4MShares$179 Million6.61% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$173 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$138 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$136 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $947M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...